- Home
- RFL vs GRF Comparison
RFL vs GRF Comparison
Compare RFL & GRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFL
- GRF
- Stock Information
- Founded
- RFL 2017
- GRF 1989
- Country
- RFL United States
- GRF United States
- Employees
- RFL N/A
- GRF N/A
- Industry
- RFL Real Estate
- GRF Finance/Investors Services
- Sector
- RFL Finance
- GRF Finance
- Exchange
- RFL Nasdaq
- GRF Nasdaq
- Market Cap
- RFL 48.4M
- GRF N/A
- IPO Year
- RFL N/A
- GRF N/A
- Fundamental
- Price
- RFL $1.87
- GRF $9.80
- Analyst Decision
- RFL
- GRF
- Analyst Count
- RFL 0
- GRF 0
- Target Price
- RFL N/A
- GRF N/A
- AVG Volume (30 Days)
- RFL 58.1K
- GRF 3.0K
- Earning Date
- RFL 12-12-2024
- GRF 01-01-0001
- Dividend Yield
- RFL N/A
- GRF 3.70%
- EPS Growth
- RFL N/A
- GRF N/A
- EPS
- RFL N/A
- GRF 1.16
- Revenue
- RFL $540,000.00
- GRF N/A
- Revenue This Year
- RFL N/A
- GRF N/A
- Revenue Next Year
- RFL N/A
- GRF N/A
- P/E Ratio
- RFL N/A
- GRF $8.15
- Revenue Growth
- RFL 92.86
- GRF N/A
- 52 Week Low
- RFL $1.29
- GRF $7.93
- 52 Week High
- RFL $2.50
- GRF $10.19
- Technical
- Relative Strength Index (RSI)
- RFL 43.35
- GRF 50.49
- Support Level
- RFL $1.86
- GRF $9.62
- Resistance Level
- RFL $2.50
- GRF $9.91
- Average True Range (ATR)
- RFL 0.12
- GRF 0.10
- MACD
- RFL -0.05
- GRF -0.00
- Stochastic Oscillator
- RFL 4.30
- GRF 47.37
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd.